Wolf AM - Search Results

1

Naturally occurring CD4+ CD25+ regulatory T cells modulate the haematopoietic potential of human stem cells in vitro.

Salvador C, Steurer M, Tzankov A, Wolf AM, Gastl G, Konwalinka G, Wolf D. Salvador C, et al. Among authors: wolf d, wolf am. Br J Haematol. 2008 Sep;142(5):845-7. doi: 10.1111/j.1365-2141.2008.07190.x. Epub 2008 Jul 8. Br J Haematol. 2008. PMID: 18637805 Free article. No abstract available.

2

Comment on "Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice".

Wolf D, Wolf AM, Tzankov A. Wolf D, et al. Among authors: wolf am. J Immunol. 2010 Apr 15;184(8):4051. doi: 10.4049/jimmunol.1090014. J Immunol. 2010. PMID: 20368283 No abstract available.

3

CCR 20th Anniversary Commentary: From Regulatory T Cells to Checkpoint Monoclonal Antibodies--Immuno-oncology Advances Clinical Cancer Research.

Wolf D, Wolf AM. Wolf D, et al. Among authors: wolf am. Clin Cancer Res. 2015 Jun 15;21(12):2657-9. doi: 10.1158/1078-0432.CCR-14-2558. Clin Cancer Res. 2015. PMID: 26078428

4

Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.

Wolf D, Rumpold H, Koppelstätter C, Gastl GA, Steurer M, Mayer G, Gunsilius E, Tilg H, Wolf AM. Wolf D, et al. Among authors: wolf am. Cancer Immunol Immunother. 2006 Oct;55(10):1198-208. doi: 10.1007/s00262-005-0107-5. Epub 2005 Dec 16. Cancer Immunol Immunother. 2006. PMID: 16362412 Free PMC article.

5

Mesenchymal stem cells as cellular immunosuppressants.

Wolf D, Wolf AM. Wolf D, et al. Among authors: wolf am. Lancet. 2008 May 10;371(9624):1553-4. doi: 10.1016/S0140-6736(08)60666-2. Lancet. 2008. PMID: 18468526 No abstract available.

6

CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.

Wolf D, Hochegger K, Wolf AM, Rumpold HF, Gastl G, Tilg H, Mayer G, Gunsilius E, Rosenkranz AR. Wolf D, et al. Among authors: wolf am. J Am Soc Nephrol. 2005 May;16(5):1360-70. doi: 10.1681/ASN.2004100837. Epub 2005 Mar 23. J Am Soc Nephrol. 2005. PMID: 15788479

7

Increase of regulatory T cells in the peripheral blood of cancer patients.

Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B. Wolf AM, et al. Among authors: wolf d. Clin Cancer Res. 2003 Feb;9(2):606-12. Clin Cancer Res. 2003. PMID: 12576425

8

Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.

Kircher B, Schumacher P, Petzer A, Hoflehner E, Haun M, Wolf AM, Nachbaur D, Gastl G. Kircher B, et al. Among authors: wolf am. Eur J Haematol. 2009 Jul;83(1):48-56. doi: 10.1111/j.1600-0609.2009.01242.x. Epub 2009 Feb 17. Eur J Haematol. 2009. PMID: 19226363

9

Immune cells in colorectal cancer.

Wolf D, Marth C, Wolf AM. Wolf D, et al. Among authors: wolf am. N Engl J Med. 2006 Apr 6;354(14):1531-2; author reply 1531-2. doi: 10.1056/NEJMc060116. N Engl J Med. 2006. PMID: 16598053 No abstract available.

10

Regulatory T cells in cancer biology: a possible new target for biochemical therapies.

Wolf D, Rumpold H, Wolf AM. Wolf D, et al. Among authors: wolf am. Mini Rev Med Chem. 2006 May;6(5):509-13. doi: 10.2174/138955706776876230. Mini Rev Med Chem. 2006. PMID: 16719824 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters